Nevertheless the clear in vitro evidence for NO as the major inhibitor of WPB exocytosis and Ang-2 release, and the findings in other disease settings such as malaria [23], make it more likely that impaired NO bioavailability is a significant contributor to Ang-2 release in sepsis. The gene discussed is ANGPT2; the disease is malaria.